Literature DB >> 6788416

Monoclonal autoantibody production by hybrid cell lines.

J L Klotz, M L Phillips, M M Miller, R L Teplitz.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6788416     DOI: 10.1016/0090-1229(81)90130-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  7 in total

1.  Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1).

Authors:  T Nakaki; R J Deans; A S Lee
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

Review 2.  Purification of antigens and monoclonal antibodies.

Authors:  D Williams
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

Review 3.  Hybridomas: a new dimension in biological analyses.

Authors:  R H Kennett
Journal:  In Vitro       Date:  1981-12

4.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

5.  In vivo clearance and tissue uptake of an anti-DNA monoclonal antibody and its complexes with DNA.

Authors:  E Ben Chetrit; E H Dunsky; S Wollner; D Eilat
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

6.  Homology of the NH2-terminal amino acid sequences of the heavy and light chains of human monoclonal lupus autoantibodies containing the dominant 16/6 idiotype.

Authors:  P M Atkinson; G W Lampman; B C Furie; Y Naparstek; R S Schwartz; B D Stollar; B Furie
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

7.  Description and partial characterization of a nucleolar RNA-associated autoantigen defined by a human monoclonal antibody.

Authors:  N Chiorazzi; W H Reeves
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.